Tibial aplasia-ectrodactyly syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:3329OMIM:119100Q73.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Tibial aplasia-ectrodactyly syndrome is a rare congenital limb malformation disorder characterized by the absence or severe underdevelopment (aplasia or hypoplasia) of the tibia (the larger bone of the lower leg) combined with ectrodactyly, also known as split hand/split foot malformation (SHFM). Ectrodactyly involves the absence of one or more central digits of the hands and/or feet, often resulting in a characteristic cleft or lobster-claw appearance. The condition primarily affects the skeletal and musculoskeletal systems, with limb abnormalities that can be bilateral or unilateral and may vary in severity even within the same family. Affected individuals typically present at birth with shortened or absent tibiae, leading to significant lower limb deformity and impaired mobility. The split hand/foot malformation can affect both upper and lower extremities. Additional features may include absence or hypoplasia of the fibula in some cases, though the hallmark combination is tibial deficiency with ectrodactyly. The condition is generally not associated with intellectual disability or major internal organ involvement, though thorough evaluation is recommended to rule out associated anomalies. Treatment is primarily supportive and surgical. Orthopedic interventions may include limb reconstruction, prosthetic fitting, and corrective surgeries to improve function and mobility. Hand surgery may be considered to optimize grip and hand function. A multidisciplinary approach involving orthopedic surgeons, prosthetists, physical therapists, and genetic counselors is recommended. Genetic counseling is important for affected families given the hereditary nature of the condition. No curative therapy currently exists, and management focuses on maximizing functional independence and quality of life.

Also known as:

Clinical phenotype terms— hover any for plain English:

Femoral bowingHP:0002980Fibular hypoplasiaHP:0003038Short femurHP:0003097Aplasia/Hypoplasia of the tibiaHP:0005772Patellar aplasiaHP:0006443Aplasia/Hypoplasia of the ulnaHP:0006495Popliteal pterygiumHP:0009756EctrodactylyHP:0100257
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Tibial aplasia-ectrodactyly syndrome.

View clinical trials →

No actively recruiting trials found for Tibial aplasia-ectrodactyly syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Tibial aplasia-ectrodactyly syndrome community →

No specialists are currently listed for Tibial aplasia-ectrodactyly syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Tibial aplasia-ectrodactyly syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Tibial aplasia-ectrodactyly syndromeForum →

No community posts yet. Be the first to share your experience with Tibial aplasia-ectrodactyly syndrome.

Start the conversation →

Latest news about Tibial aplasia-ectrodactyly syndrome

No recent news articles for Tibial aplasia-ectrodactyly syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Tibial aplasia-ectrodactyly syndrome

What is Tibial aplasia-ectrodactyly syndrome?

Tibial aplasia-ectrodactyly syndrome is a rare congenital limb malformation disorder characterized by the absence or severe underdevelopment (aplasia or hypoplasia) of the tibia (the larger bone of the lower leg) combined with ectrodactyly, also known as split hand/split foot malformation (SHFM). Ectrodactyly involves the absence of one or more central digits of the hands and/or feet, often resulting in a characteristic cleft or lobster-claw appearance. The condition primarily affects the skeletal and musculoskeletal systems, with limb abnormalities that can be bilateral or unilateral and may

How is Tibial aplasia-ectrodactyly syndrome inherited?

Tibial aplasia-ectrodactyly syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Tibial aplasia-ectrodactyly syndrome typically begin?

Typical onset of Tibial aplasia-ectrodactyly syndrome is neonatal. Age of onset can vary across affected individuals.